Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
2014367 citationsJournal Articlehybrid Open Access
Field-Weighted Citation Impact: 32.18
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD | Researchclopedia